Post-earnings recap
Reported
Thu, Oct 17, 2024
EPS actual
$8.37
EPS est.
$9.70
EPS surprise
-13.69%
1-day move
-10.59%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Elevance Health's earnings report shows a significant miss on EPS, which likely contributed to the stock's sharp decline of 10.59%. The lack of revenue details and guidance may raise concerns among investors about the company's short-term performance. Management's defensive tone suggests they are aware of the challenges ahead but remain focused on long-term strategies.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $8.37 | N/A | -13.69% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a cautious outlook, reflecting on the difficulties encountered during the quarter. They reiterated their commitment to long-term growth.
Management acknowledged the challenges faced in the quarter.
They emphasized a focus on long-term strategies despite short-term setbacks.